Please use this identifier to cite or link to this item:
Long-term low dose interferon alpha-2b in the treatment of chronic hepatitis B in multi-ethnic patients in Hawaii.
|Title:||Long-term low dose interferon alpha-2b in the treatment of chronic hepatitis B in multi-ethnic patients in Hawaii.|
|Authors:||Ching, Nathaniel P. H.|
Or, F W
show 2 moreChing, Natascha W. H.
|Issue Date:||Oct 1996|
|Abstract:||The antiviral and immunomodulatory effects of interferon were assessed in the treatment of chronic hepatitis B in multi-ethnic patients to prevent viral replication and chronic liver damage. Five million units of recombinant interferon alpha-2b were administered three times a week for 48 weeks to a group of 18 chronic active hepatitis B patients. A complete response was defined as seroconversion to anti-HBe and/or loss of HBe antigen. Seroconversion to anti-HBe in 5 of 12 (42%) chronic active hepatitis B patients occurred after 48 weeks of therapy. HBV-DNA decreased to undetectable levels in 8 of 12 (67%) patients. This chronic low-dose interferon administration regimen demonstrated responses comparable to other studies.|
|Appears in Collections:||Hawaii Medical Journal Articles For 1996|
Items in eVols are protected by copyright, with all rights reserved, unless otherwise indicated.